{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:53:20Z","timestamp":1792601600395,"version":"4.5.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"Importance<\/jats:title>Genome-wide association studies have identified germline variants associated with the development of papillary thyroid carcinoma (PTC) that can be used to construct a polygenic score (PGS). It is important to determine whether patients with higher germline genetic risk, as summarized using PGS, present with more aggressive disease and\/or develop worse clinical outcomes.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess whether germline risk defined by PGS is associated with clinicopathologic features and survival outcomes for patients with PTC.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This retrospective cohort study included patients with newly diagnosed PTC who presented to The University of Texas MD Anderson Cancer Center for treatment between 1999 and 2014, with a median follow-up of 12 years. Data were analyzed from December 2023 to April 2024.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Germline risk, as defined by PGS.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Genomic DNA was extracted from buffy coat cells isolated from peripheral blood samples, and genotyping for germline polymorphisms was performed. Germline risk for PTC was estimated with a previously validated PGS calculated from 10 single-nucleotide variations identified through genome-wide association studies. Stage; PTC-specific survival, defined as the time from PTC diagnosis to death caused by PTC; and overall survival, defined as the time from PTC diagnosis to death by any cause, were analyzed.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 366 patients were included in the study (261 women [71.3%]; mean [SD] age at diagnosis, 44.3 [13.8] years). There was a statistically significant association between higher PGS and multifocality (\u03b2 [SE], 0.40 [0.23]; P<\/jats:italic>\u2009=\u2009.045) and cervical lymph node involvement (N stage) (\u03b2 [SE], 0.62 [0.35]; P<\/jats:italic>\u2009=\u2009.009) at diagnosis. PGS was associated with PTC-specific survival (hazard ratio, 2.66; 95% CI, 1.03-6.85; P<\/jats:italic>\u2009=\u2009.04), but this association was not independent of age and overall stage. There was not a statistically significant association between PGS and overall survival.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>Findings of this cohort study suggest that patients with a higher germline risk of PTC, as estimated by PGS, present with more aggressive clinicopathologic features. These results contribute to the current understanding of inherited risk in PTC and how germline variants could potentially contribute to disease presentation and clinical outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoto.2024.3963","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T16:34:03Z","timestamp":1732725243000},"page":"113","source":"Crossref","is-referenced-by-count":2,"title":["Polygenic Score for Clinicopathologic Features and Survival Outcomes in Papillary Thyroid Carcinoma"],"prefix":"10.1001","volume":"151","author":[{"given":"Sophie","family":"Li","sequence":"first","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"School of Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guibin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitrayee","family":"Goswami","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Zafereo","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven I.","family":"Sherman","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich M.","family":"Sturgis","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"ooi240087r1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"ooi240087r2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and clinical perspectives on thyroid cancer.","volume":"375","author":"Fagin","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"ooi240087r3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma.","volume":"159","author":"Agrawal","year":"2014","journal-title":"Cell"},{"issue":"3","key":"ooi240087r4","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/SLA.0b013e318148563d","article-title":"The prevalence and prognostic value of BRAF mutation in thyroid cancer.","volume":"246","author":"Kebebew","year":"2007","journal-title":"Ann Surg"},{"issue":"5","key":"ooi240087r5","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.21037\/gs-20-430","article-title":"Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma\u2014a contemporary systematic review.","volume":"9","author":"Rashid","year":"2020","journal-title":"Gland Surg"},{"issue":"8","key":"ooi240087r6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jnci\/95.8.625","article-title":"BRAF mutation in papillary thyroid carcinoma.","volume":"95","author":"Cohen","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"ooi240087r7","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1038\/s41467-020-18246-6","article-title":"Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.","volume":"11","author":"Rashkin","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"ooi240087r8","doi-asserted-by":"publisher","first-page":"14517","DOI":"10.1038\/ncomms14517","article-title":"A genome-wide association study yields five novel thyroid cancer risk loci.","volume":"8","author":"Gudmundsson","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"ooi240087r9","doi-asserted-by":"publisher","first-page":"15966","DOI":"10.1038\/ncomms15966","article-title":"Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer.","volume":"8","author":"Son","year":"2017","journal-title":"Nat Commun"},{"issue":"11","key":"ooi240087r10","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1073\/pnas.1919976117","article-title":"Assessing thyroid cancer risk using polygenic risk scores.","volume":"117","author":"Liyanarachchi","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ooi240087r11","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41467-021-21288-z","article-title":"Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts.","volume":"12","author":"Graff","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"ooi240087r12","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1158\/1055-9965.EPI-21-0448","article-title":"Polygenic risk score improves risk stratification and prediction of subsequent thyroid cancer after childhood cancer.","volume":"30","author":"Song","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"ooi240087r13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ajhg.2020.08.025","article-title":"Cancer PRSweb: an online repository with polygenic risk scores for major cancer traits and their evaluation in two independent biobanks.","volume":"107","author":"Fritsche","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"7","key":"ooi240087r14","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1158\/0008-5472.CAN-20-0177","article-title":"Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression, and drug response.","volume":"81","author":"Zhang","year":"2021","journal-title":"Cancer Res"},{"issue":"5","key":"ooi240087r15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tig.2020.10.005","article-title":"Germline variants that affect tumor progression.","volume":"37","author":"Chatrath","year":"2021","journal-title":"Trends Genet"},{"issue":"11","key":"ooi240087r16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/jamaoto.2013.4987","article-title":"Establishing a familial basis for papillary thyroid carcinoma using the Utah Population Database.","volume":"139","author":"Oakley","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"5","key":"ooi240087r17","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/cncr.26398","article-title":"Family history of cancer and risk of sporadic differentiated thyroid carcinoma.","volume":"118","author":"Xu","year":"2012","journal-title":"Cancer"},{"issue":"4","key":"ooi240087r18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/cen.12859","article-title":"Clinicopathological features and prognosis of familial papillary thyroid carcinoma\u2014a large-scale, matched, case-control study.","volume":"84","author":"Cao","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ooi240087r19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1200855","article-title":"Clinical relevance and outcome of familial papillary thyroid cancer: a single institution study of 626 familial cases.","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"ooi240087r20","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1210\/er.2007-0007","article-title":"BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications.","volume":"28","author":"Xing","year":"2007","journal-title":"Endocr Rev"},{"issue":"11","key":"ooi240087r21","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.1210\/jc.2003-030838","article-title":"BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"ooi240087r22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00268-011-1383-1","article-title":"BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer.","volume":"36","author":"Kim","year":"2012","journal-title":"World J Surg"},{"issue":"6","key":"ooi240087r23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/ct.2022;34.259-262","article-title":"BRAF V600E-mutant papillary thyroid cancer is a heterogeneous malignancy with varied molecular signaling and clinical characteristics.","volume":"34","author":"Kotwal","year":"2022","journal-title":"Clin Thyroidol"},{"issue":"1","key":"ooi240087r24","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1210\/clinem\/dgad407","article-title":"Association of polygenic score with tumor molecular subtypes in papillary thyroid carcinoma.","volume":"109","author":"Wang","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ooi240087r25","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s002680010233","article-title":"Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment.","volume":"24","author":"Musholt","year":"2000","journal-title":"World J Surg"},{"issue":"4","key":"ooi240087r26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000506955","article-title":"Long-term clinical outcome in familial and sporadic papillary thyroid carcinoma.","volume":"9","author":"Capezzone","year":"2020","journal-title":"Eur Thyroid J"},{"issue":"12","key":"ooi240087r27","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ajhg.2022.10.009","article-title":"Systematic comparison of family history and polygenic risk across 24 common diseases.","volume":"109","author":"Mars","year":"2022","journal-title":"Am J Hum Genet"},{"key":"ooi240087r28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104454","article-title":"Prognostic evaluation of polygenic risk score underlying pan-cancer analysis: evidence from two large-scale cohorts.","volume":"89","author":"Xin","year":"2023","journal-title":"EBioMedicine"},{"issue":"2","key":"ooi240087r29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics.","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"5","key":"ooi240087r31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.18.00085","article-title":"High preponderance of BRAF V600E mutation in papillary thyroid carcinoma among Filipinos: a clinicopathologic study.","volume":"5","author":"Espiritu","year":"2019","journal-title":"J Glob Oncol"},{"issue":"9","key":"ooi240087r32","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1530\/EC-19-0376","article-title":"BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry.","volume":"8","author":"Estrada-Fl\u00f3rez","year":"2019","journal-title":"Endocr Connect"},{"key":"ooi240087r30","unstructured":"Cancer stat facts: thyroid cancer. National Cancer Institute. Accessed February 24, 2024. https:\/\/seer.cancer.gov\/statfacts\/html\/thyro.html"}],"container-title":["JAMA Otolaryngology\u2013Head & Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2827135\/jamaotolaryngology_li_2024_oi_240087_1738973199.55391.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:16:55Z","timestamp":1739463415000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2827135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2024.3963","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,1]]}}}